[go: up one dir, main page]

EP0270503A3 - Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use - Google Patents

Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use Download PDF

Info

Publication number
EP0270503A3
EP0270503A3 EP87830386A EP87830386A EP0270503A3 EP 0270503 A3 EP0270503 A3 EP 0270503A3 EP 87830386 A EP87830386 A EP 87830386A EP 87830386 A EP87830386 A EP 87830386A EP 0270503 A3 EP0270503 A3 EP 0270503A3
Authority
EP
European Patent Office
Prior art keywords
otilonium
bromure
pharmaceutical formulation
gastrointestinal tract
dci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP87830386A
Other versions
EP0270503B1 (en
EP0270503A2 (en
Inventor
Alessandro Casini
Sandro Parti
Paolo Bucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
A Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Menarini Industrie Farmaceutiche Riunite SRL filed Critical A Menarini Industrie Farmaceutiche Riunite SRL
Priority to AT87830386T priority Critical patent/ATE94388T1/en
Publication of EP0270503A2 publication Critical patent/EP0270503A2/en
Publication of EP0270503A3 publication Critical patent/EP0270503A3/en
Application granted granted Critical
Publication of EP0270503B1 publication Critical patent/EP0270503B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)
  • Steroid Compounds (AREA)

Abstract

Use of bromure d'otilonium, that is otilonii bromidum, for local application in the gastrointestinal tract of the digestive system and relative pharmaceutical formulation appropriate for such use, to obtain the arrest of the motility in order to allow endoscopic manoeuvres for diagnostic and therapeutic purposes.
EP87830386A 1986-11-04 1987-11-03 Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use Expired - Lifetime EP0270503B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT87830386T ATE94388T1 (en) 1986-11-04 1987-11-03 USE OF OTILONIUM BROMIDE FOR TOPICAL APPLICATION IN THE GASTROINTESTINAL TRACT AND RELATIVE APPROPRIATE PHARMACEUTICAL FORMULATION.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8609514A IT1216283B (en) 1986-11-04 1986-11-04 USE OF OCTILONIUM BROMIDE (DCI) FOR TOPICAL APPLICATION IN THE GASTRO-INTESTINAL TRACT AND RELATED PHARMACEUTICAL FORMULATION APPROPRIATE FOR SUCH USE.
IT951486 1986-11-04

Publications (3)

Publication Number Publication Date
EP0270503A2 EP0270503A2 (en) 1988-06-08
EP0270503A3 true EP0270503A3 (en) 1990-04-18
EP0270503B1 EP0270503B1 (en) 1993-09-15

Family

ID=11131395

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87830386A Expired - Lifetime EP0270503B1 (en) 1986-11-04 1987-11-03 Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use

Country Status (8)

Country Link
US (1) US4978772A (en)
EP (1) EP0270503B1 (en)
JP (1) JP2514670B2 (en)
AT (1) ATE94388T1 (en)
CA (1) CA1311419C (en)
DE (1) DE3787448T2 (en)
ES (1) ES2058138T3 (en)
IT (1) IT1216283B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503889B1 (en) * 2002-07-20 2005-07-26 한국과학기술연구원 Absorption enhancer of anticancer drugs
WO2010092436A1 (en) * 2009-02-12 2010-08-19 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of simethicone and otilonium
EP2481403A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Pharmaceutical combination of otilonium and trimebutine
EP2481395A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, effervescent tablet and dry syrup of otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHIR. GASTROENTER, vol. 15, no. 2, 1981, pages 288-294, L. CAPURSO: "Confronto fraottilonio bromuro ed atropina nella premedicazione per endoscopia perorale. Uno studie preliminare". *
GASTROENTEROLOGIA Y HEPATOLOGIA, vol. 7, no. 7, 1984, pages 362-368, J.M. BORDAS et al.: "Bromuro de octilonio como premedicacion en fibrocolonoscopia". *
MED. CLIN., vol. 89, no. 6, 1987, pages 230-234, J.M. BORDAS et al.: "Papilotomia endoscopica. Analisis comparativo del efecto del ceruletide y del bromuro de octilonio como modificadores de la motilidad del duodeno y del esfinter papilar". *

Also Published As

Publication number Publication date
US4978772A (en) 1990-12-18
JPS63130530A (en) 1988-06-02
DE3787448D1 (en) 1993-10-21
JP2514670B2 (en) 1996-07-10
ES2058138T3 (en) 1994-11-01
IT1216283B (en) 1990-02-22
IT8609514A0 (en) 1986-11-04
EP0270503B1 (en) 1993-09-15
DE3787448T2 (en) 1994-01-13
EP0270503A2 (en) 1988-06-08
CA1311419C (en) 1992-12-15
ATE94388T1 (en) 1993-10-15

Similar Documents

Publication Publication Date Title
GB2259647B (en) Medicaments for treating gastrointestinal disorders
IT8567279A1 (en) EQUIPMENT FOR THE CONTROLLED APPLICATION, ON HUMAN TISSUE, OF REDUCING SUBSTANCES TO REALIZE MICROABRASIONS.
SE9201930D0 (en) GASTRIC ANTIBACTERIAL TREATMENT
EP0270503A3 (en) Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use
EG18842A (en) Process for preparing of dimethylpolysiloxone and their use for the treatment of disorders of the gastrointestinal tract
EP0167995A3 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
IT1157217B (en) BLOOD OXYGENATION PROCEDURE AND DEVICE
CA2252399A1 (en) Composition for demonstrating the presence of ammonia in exhaled air
FR2595247B1 (en) USE IN COSMETOLOGY OF MUCUS EXTRACTS OR DIGESTIVE SUGAS OF GASTEROPODS AND PREPARATION OF SUCH EXTRACTS
GB2134783A (en) Medical preparation having antitumoral effect
FR2601434B1 (en) CONNECTING DEVICE FOR ANESTHESIA AND ARTIFICIAL BREATHING APPARATUS
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
FR2607395B1 (en) DEVICE FOR THE RESUSCITATION OF WALNUTS BY LIQUID INSPIRATION AND SIMULTANEOUS AIR BLOWING
Salmon Gastrointestinal Endoscopy (Advances in Diagnosis and Therapy).
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
Kos-Golja The antibiotic treatment of rheumatic diseases.
TAKEMURA et al. A Case Report of Reticulum Cell Sarcoma of the Stomach
Sanderson Investigations on the nutritional care of dialysis patients
IT8500516V0 (en) GYMNASTICS-VERTICALLINEA-TOOL TO PREVENT, TREAT, IMPROVE THE HEALTH AND APPEARANCE OF THE HUMAN BODY
IT8500609A0 (en) GYMNASTICS EQUIPMENT TO PREVENT, TREAT, IMPROVE THE HEALTH AND APPEARANCE OF THE HUMAN BODY
CA2107884A1 (en) Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
IT1254745B (en) Cyclophosphazines containing acetylsalicylic acid groups, process of preparation and use
FI875232A0 (en) ANORDING FOR THE MAINTENANCE OF SAILS, SAILS AND ENDED PATIENTS.
GR3001809T3 (en) Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments
IT208536Z2 (en) DISPOSABLE VAGINAL CANNULA STRUCTURE, FOR THE APPLICATION OF POMATE, SEMI-DENSE AND SIMILAR MEDICATIONS.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR LI LU NL SE

17P Request for examination filed

Effective date: 19900413

17Q First examination report despatched

Effective date: 19910918

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR LI LU NL SE

REF Corresponds to:

Ref document number: 94388

Country of ref document: AT

Date of ref document: 19931015

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3787448

Country of ref document: DE

Date of ref document: 19931021

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3009044

EPTA Lu: last paid annual fee
ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2058138

Country of ref document: ES

Kind code of ref document: T3

EAL Se: european patent in force in sweden

Ref document number: 87830386.6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19990914

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19990923

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19991103

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19991113

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19991130

Year of fee payment: 13

Ref country code: AT

Payment date: 19991130

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19991217

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20001103

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20001103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 20001129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20001130

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20001130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010601

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20001103

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

EUG Se: european patent has lapsed

Ref document number: 87830386.6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010731

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20010601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20011023

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20011026

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20011115

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20011121

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021130

BERE Be: lapsed

Owner name: A. *MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L

Effective date: 20021130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030609

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20031213